Light Sciences Oncology Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Light Sciences Oncology Inc. - overview
Established
1994
Location
Bellevue, WA, US
Primary Industry
Pharmaceuticals
About
Founded in 1994 and based in Washington, US, Light Sciences Oncology Inc. develops light-activated drug products to treat patients with solid tumor cancers as well as benign prostatic hyperplasia (BPH). The company offers Aptocine, a water-soluble drug design to provide treatments for patients with hepatocellular carcinoma (HCC) and metastatic colorectal cancer (MCRC).
Current Investors
EW Healthcare Partners, Adams Street Partners, Essex Woodlands
Primary Industry
Pharmaceuticals
Sub Industries
Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.lsoncology.com
Total Amount Raised
Subscriber access only
Light Sciences Oncology Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Light Sciences Oncology Inc. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.